Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assays

BACKGROUND: There is scant information on the accuracy of different assays used to measure anti-infliximab antibodies (ADAs), especially in the presence of detectable infliximab (IFX). We thus aimed to evaluate and compare three different assays for the detection of IFX and ADAs and to clarify the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Afonso, Joana, Lopes, Susana, Gonçalves, Raquel, Caldeira, Paulo, Lago, Paula, Tavares de Sousa, Helena, Ramos, Jaime, Gonçalves, Ana Rita, Ministro, Paula, Rosa, Isadora, Vieira, Ana Isabel, Coelho, Rosa, Tavares, Patrícia, Soares, João, Sousa, Ana Lúcia, Carvalho, Diana, Sousa, Paula, da Silva, João Pereira, Meira, Tânia, Silva Ferreira, Filipa, Dias, Cláudia Camila, Chowers, Yehuda, Ben-Horin, Shomron, Magro, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5076767/
https://www.ncbi.nlm.nih.gov/pubmed/27803733
http://dx.doi.org/10.1177/1756283X16658223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5076767/
https://www.ncbi.nlm.nih.gov/pubmed/27803733
http://dx.doi.org/10.1177/1756283X16658223

Ejemplares similares